BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 426501)

  • 21. Comparative in-vitro activity of ticarcillin and carbenicillin against 100 clinical isolates of Pseudomonas aeruginosa.
    Pearman JW; Kosaras FP; Harper WE
    Med J Aust; 1978 Apr; 1(8):452-4. PubMed ID: 96319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics.
    Gwynn MN; Rolinson GN
    Infection; 1980; 8(2):73-80. PubMed ID: 6771215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.
    Sobel JD; Levison ME; Kaye D
    Infection; 1980; 8(3):121-2. PubMed ID: 6448229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of inoculum size on the activity of carboxy- and ureido-penicillins and effects of combinations of ureido-penicillins with aminoglycosides against resistant Pseudomonas aeruginosa.
    Watanakunakorn C
    J Antimicrob Chemother; 1986 Jan; 17(1):91-5. PubMed ID: 3081474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of ampicillin-resistant Haemophilus influenzae to seven penicillins.
    Thornsberry C; Baker CN; Kirven LA; Swenson JM
    Antimicrob Agents Chemother; 1976 Jan; 9(1):70-3. PubMed ID: 1083202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa.
    Wald ER; Standiford HC; Tatem BA; Calia FM; Hornick RB
    Antimicrob Agents Chemother; 1975 Mar; 7(3):336-40. PubMed ID: 806263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
    Reimer LG; Mirrett S; Reller LB
    Antimicrob Agents Chemother; 1980 Mar; 17(3):412-6. PubMed ID: 6448577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piperacillin: evaluation against inpatient and gentamicin-resistant bacteria.
    Rosenthal SL; Freundlich LF; Rendler S; Winn R; Japko LI
    Scand J Infect Dis; 1980; 12(2):136-8. PubMed ID: 6445587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenes.
    Basker MJ; Edmondson RA; Sutherland R
    Infection; 1979; 7(2):67-73. PubMed ID: 108220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
    Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
    J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative activity of mezlocillin, penicillin, ampicillin, carbenicillin, and ticarcillin against gram-positive bacteria and Haemophilus influenzae.
    Sanders CC
    Antimicrob Agents Chemother; 1981 Dec; 20(6):843-6. PubMed ID: 6459766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test.
    Barry AL; Jones RN; Thornsberry C
    Antimicrob Agents Chemother; 1981 Oct; 20(4):525-9. PubMed ID: 6211134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of the Bacteroides fragilis group of anaerobes to carbenicillin and ticarcillin.
    Garcia Rodriguez JA; Garcia Sanchez JE; Gomez Garcia AC; Prieto Prieto J
    J Antimicrob Chemother; 1978 May; 4(3):284-6. PubMed ID: 670123
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.
    Barry AL; Thornsberry C; Jones RN; Gavan TL
    Cleve Clin Q; 1980; 47(4):311-9. PubMed ID: 6451334
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of disc-diffusion and plate-incorporation susceptibility testing of gram-negative bacilli to ticarcillin, piperacillin and ticarcillin/clavulanate.
    Elston RA; Swann RA; Fraise A
    J Antimicrob Chemother; 1989 Feb; 23(2):285-7. PubMed ID: 2708186
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of ticarcillin and carbenicillin activity against random and select populations Pseudomonas aeruginosa.
    Prior RB; Fass RJ
    Antimicrob Agents Chemother; 1978 Feb; 13(2):184-7. PubMed ID: 417671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The comparative synergistic activity of amikacin, gentamicin, netilmicin and azlocillin, mezlocillin, carbenicillin and ticarcillin against Serratia marcescens.
    Fu KP; Neu HC
    J Antibiot (Tokyo); 1978 Feb; 31(2):135-40. PubMed ID: 344298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tobramycin inactivation by carbenicillin, ticarcillin, and piperacillin.
    Konishi H; Goto M; Nakamoto Y; Yamamoto I; Yamashina H
    Antimicrob Agents Chemother; 1983 May; 23(5):653-7. PubMed ID: 6223576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms.
    Verbist L
    Antimicrob Agents Chemother; 1979 Aug; 16(2):115-9. PubMed ID: 485123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.
    Rotstein C; Amsterdam D; Beam T; Gorzynski E
    Diagn Microbiol Infect Dis; 1989; 12(2):157-63. PubMed ID: 2752713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.